Washington 2023-2024 Regular Session

Washington Senate Bill SB5804

Introduced
1/8/24  
Refer
1/8/24  
Report Pass
1/17/24  
Engrossed
2/1/24  
Refer
2/5/24  
Report Pass
2/19/24  
Refer
2/21/24  
Enrolled
3/8/24  
Chaptered
3/19/24  

Caption

Revised for 1st Substitute: Concerning opioid overdose reversal medication in public schools.Original: Concerning opioid overdose reversal medication in high schools.

Impact

The proposed changes in SB5804 could significantly impact state laws related to medication access in schools, particularly concerning emergency health responses. By mandating schools to have opioid reversal medication available, the bill presents an important preventive measure against the risks associated with opioid usage among youth. Furthermore, it could influence school district policies regarding health resources and emergency preparedness, ultimately fostering a safer educational atmosphere.

Summary

SB5804, which focuses on opioid overdose reversal medication, has been revised to target its implementation in public schools. The initial version of the bill aimed solely at high schools, and the amendment extends the provision to all public schools. This legislative change is designed to address the ongoing opioid crisis by ensuring that students have access to life-saving medication in the event of an overdose, thus potentially saving lives and promoting student health and safety within educational environments.

Sentiment

The sentiment surrounding SB5804 appears generally positive, with strong support from various stakeholders, including healthcare advocates and educators who recognize the need for proactive measures to combat the opioid epidemic. The acknowledgment of opioid threats in schools has underscored the urgency for such legislation, with proponents arguing that access to reversal medication is a critical tool for safeguarding students' lives. However, some concerns about implementation logistics have also been raised, indicating a need for proper training and resources for school staff.

Contention

Key points of contention in the discussions surrounding SB5804 include the necessary training and resources for school personnel to administer opioid reversal medication and the potential costs associated with stocking such medications. While the bill has garnered broad support for its life-saving intentions, critics emphasize the importance of adequate preparation and funding to ensure that schools can effectively manage these responsibilities. The challenge lies in balancing the urgency of addressing opioid overdoses with the practical realities of implementation in the school setting.

Companion Bills

WA HB2029

Crossfiled Concerning opioid overdose reversal medication in high schools.

Previously Filed As

WA HB2029

Concerning opioid overdose reversal medication in high schools.

WA HB1413

Prohibiting government purchases of opioid overdose reversal medications from certain entities.

WA LB195

Provide immunity for administration of naloxone, nalmefene, or other federally approved opioid overdose reversal medications

WA SB5229

Facilitating civil commitment for treatment for a person requiring revival by opioid overdose reversal medication.

WA HB05053

An Act Concerning Opioids And Access To Overdose Reversal Drugs.

WA HB1227

Opioid overdose reversal medication in schools.

WA SB472

Pupil health: opioid overdose reversal medication.

WA HB852

Educational Institutions - Opioid Overdose-Reversing Medications - Policy Requirements (Protecting Our Kids From Overdoses Act)

WA AB2998

Opioid overdose reversal medications: pupil administration.

WA HB1121

Public Health - Opioids and Opioid Overdose Reversal Drugs - Information

Similar Bills

No similar bills found.